StockIQ.techTenet Healthcare Corporation (THC) Stock Analysis
Free AI-powered analysis and research for Tenet Healthcare Corporation stock
Sector: Healthcare
THC snapshot
Data as of 3 Nov 2026 close. Updated daily.
Tenet Healthcare Corporation scores 100/100 on StockIQ's model, which reads as strongly positive signals overall. The price is above its 200-day average and at 91% of its 52-week range, up 34.9% over the past year. Latest reported figures show a profit margin of 10.3%, return on equity of 37.3% and revenue growth of +6.8%.
What is driving the score
- RSI Neutral: +5
- Uptrend: +8
- MACD Bullish: +8
- Low P/E (10.4): +10
- Good Profit Margin (10.3%): +5
- Elevated Debt (1.52 D/E): -5
- Weak Liquidity (1.41 Current Ratio): -5
- Excellent ROE (37.3%): +8
- Strong Long-term Uptrend: +8
- Strong Momentum (+34.9% over 1 year): +8
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full THC report
Tenet Healthcare Corporation (THC) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze THC Now →📰 Latest Update
Raised Guidance Might Change The Case For Investing In Tenet Healthcare Stock (THC)
Sun, November 1, 2026 at 5:17 AM UTC 2 min read
Tenet Healthcare reported third quarter 2026 sales of US$5.63 billion and net income of US$1.0 billion, raising its full-year guidance for revenue, earnings, and diluted EPS. Management attributed the improved outlook to higher acuity procedures, cost control, and significant free cash flow for debt refinancing and share repurchases. The article highlights the tension between the upgraded guidance and expectations of declining earnings over the next three years, suggesting a complex investment narrative for Tenet Healthcare.